aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the target of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 99,400 shares, a decrease of 44.0% from the January 15th total of 177,500 shares. Based on an average daily trading volume, of 399,300 […]
aTyr Pharma, Inc. (NASDAQ:LIFE) Receives Average Rating of "Moderate Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.